A study examining the correlation between sirtuin expression and treatment outcomes found that SIRT4 and SIRT6 had significant prognostic value for both overall survival and progression-free survival, suggesting their potential roles as tumor suppressors in ovarian cancer [178]. This evidence concerns the gene SIRT6 and ovarian carcinoma.